alpha-aminopyridine has been researched along with Parkinson Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Higashihara, M; Ishibashi, K; Ishii, K; Iwata, A; Miura, Y; Tago, T; Toyohara, J | 1 |
| Blanca Ramírez, M; Fdez, E; Fernandez, B; Hilfiker, S; Lara Ordonez, AJ; Madero-Perez, J; Martinez-Salvador, M; Rivero-Rios, P | 1 |
| Li, GZ; Li, XT; Qin, Q; Yue, ZY; Zhang, H; Zhi, LT | 1 |
| Chen, Y; Crespo, MI; Díaz, JL; Gross, RS; Lanier, MC; Lechner, SM; Lin, E; Luo, Z; Malany, S; Moorjani, M; Rueter, JK; Santos, M; Saunders, J; Slee, DH; Tellew, JE; Vong, BG; Williams, JP; Zhang, X | 1 |
| Ballanger, B; Broussolle, E; Eche, J; Klinger, H; Le Bars, D; Lerond, J; Sgambato-Faure, V; Thobois, S; Tremblay, L; Vallet, AE | 1 |
| Dieterich, M; Jahn, K | 1 |
| Diener, HC; Drepper, J; Maschke, M; Putzki, N; Timmann, D | 1 |
| Lawson, K | 1 |
3 review(s) available for alpha-aminopyridine and Parkinson Disease
| Article | Year |
|---|---|
LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
Topics: alpha-Synuclein; Aminopyridines; Antiparkinson Agents; Autophagy; Benzamides; Endocytosis; Gene Expression; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Neurons; Parkinson Disease; Protein Domains; Protein Kinase Inhibitors; rab GTP-Binding Proteins; rab1 GTP-Binding Proteins; rab7 GTP-Binding Proteins | 2017 |
Recent advances in the diagnosis and treatment of balance disorders.
Topics: Aminopyridines; Dizziness; Humans; Parkinson Disease; Postural Balance; Vertigo; Vestibular Diseases | 2011 |
Is there a role for potassium channel openers in neuronal ion channel disorders?
Topics: Aminopyridines; Animals; Anticonvulsants; Antihypertensive Agents; Ataxia; Carbamates; Diazoxide; Epilepsy; Humans; Ion Channels; Isaacs Syndrome; Membrane Potentials; Mice; Mice, Neurologic Mutants; Mutation; Nervous System Diseases; Neuroprotective Agents; Parkinson Disease; Phenylenediamines; Potassium Channels | 2000 |
1 trial(s) available for alpha-aminopyridine and Parkinson Disease
| Article | Year |
|---|---|
Effect of functional NMDA-antagonist flupirtine on automatic postural responses in Parkinson's disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Autonomic Nervous System; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Motor Skills Disorders; Neuroprotective Agents; Parkinson Disease; Posture | 2002 |
4 other study(ies) available for alpha-aminopyridine and Parkinson Disease
| Article | Year |
|---|---|
Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.
Topics: Aminopyridines; Brain; Gliosis; Humans; Ligands; Monoamine Oxidase Inhibitors; Parkinson Disease; Positron-Emission Tomography; Quinolines | 2022 |
Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission.
Topics: Aminopyridines; Animals; Benzamides; Benzodiazepinones; Biophysical Phenomena; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mice; Mice, Transgenic; Morpholines; Mutation; Parkinson Disease; Patch-Clamp Techniques; Pyrimidines; Substantia Nigra | 2017 |
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stability.
Topics: Adenosine A2 Receptor Antagonists; Aminopyridines; Chemistry, Pharmaceutical; Drug Design; Haloperidol; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Models, Chemical; Parkinson Disease; Protein Binding; Pyrimidines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Solubility; Structure-Activity Relationship | 2008 |
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
Topics: Adult; Aged; Aminopyridines; Brain; Depression; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Piperazines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists | 2012 |